tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Michael Freeman, 16 are a BUY (84.21%), 3 are a HOLD (15.79%).
Analyst Michael Freeman, currently employed at RAYMOND JAMES, carries an average stock price target met ratio of 37.5% that have a potential upside of 20.17% achieved within 37 days.
Michael Freeman’s has documented 37 price targets and ratings displayed on 7 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TECX, Tectonic Therapeutic at 26-May-2026.
Analyst best performing recommendations are on WVE (WAVE LIFE SCIENCES LTD).
The best stock recommendation documented was for WVE (WAVE LIFE SCIENCES LTD) at 12/8/2025. The price target of $21 was fulfilled within 1 day with a profit of $2.48 (13.39%) receiving and performance score of 133.91.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 01-Sep-2022
$9
$4.24 (89.08%)
$10
5 months 11 days ago
(27-Apr-2026)
13/26 (50%)
$3.42 (61.29%)
164
Hold Since 25-Feb-2026
$7
$1.2 (20.69%)
$7
6 months 7 days ago
(31-Mar-2026)
3/7 (42.86%)
$1.6 (29.63%)
158
Hold Since 25-Jul-2024
$8
$3.24 (68.07%)
$7
9 months 1 days ago
(07-Jan-2026)
1/2 (50%)
$0.1 (1.27%)
53
Hold Since 10-Jul-2024
$8
$3.24 (68.07%)
1 years 5 months 3 days ago
(05-May-2025)
2/2 (100%)
$3.07 (62.27%)
86
Hold Since 22-Jan-2021
$3
$-1.76 (-36.97%)
2 years 2 months 6 days ago
(02-Aug-2024)
11/13 (84.62%)
$-2.63 (-46.71%)
164
Which stock is Michael Freeman most bullish on?
What Year was the first public recommendation made by Michael Freeman?
